INTRODUCTION OF VIRAL PCR DIAGNOSTICS IN PEDIATRIC RESPIRATORY TRACT INFECTION: EFFECS ON TREATMENT AND COSTS

INTRODUCTION OF VIRAL PCR DIAGNOSTICS IN PEDIATRIC RESPIRATORY TRACT INFECTION: EFFECS ON TREATMENT AND COSTS - VIDERO - trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31503

Enrollment

600

Registered

2006-10-31

Start date

2006-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory tract infection

Interventions

Treating physicians in arm A will receive the information of the PCR diagnostics within 48 hours

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Children under age of 2 months with a respiratory tract infection Children older than 2 months with a respiratory tract infection and severe respiratory problems with tachypnea, dyspnea or cyanosis

Exclusion criteria

Exclusion criteria: Age older than 12 years

Design outcomes

Primary

Measure	Time frame
Costs of viral PCR diagnostics. Cost changes as a result of introduction of PCR diagnostics. Changes in clinical decision making: duration of hospital stay, outpatient clinic visits, use of antibiotics, other medication. Use of the viral PCR in daily clinical practice.	—

Secondary

Measure	Time frame
Epidemiology of respiratory tract infections in children. New viral pathogens. Relation between viruses and laboratory parameters (CRP for example)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)